Studies primarily in colorectal and gastric cancer models have revealed a key oncogenic axis: METTL3 promotes Wnt/β-catenin signaling by recruiting YTHDF reader proteins to degrade APC mRNA [84]. This evidence concerns the gene METTL3 and gastric cancer.